Affiliations and Insurances

We accept most insurances. Also, our oncologist has admitting privileges at hospitals throughout the Valley. To find out further information about a hospital, select the link below.

http://ev-kirche-ergste.de/?debilews=single-hennef&0fa=cc St. Rose Dominican Hospital Siena Campus
3001 St. Rose Parkway
Henderson, NV 89113
702-616-5000
Website | Phone Directory | Map To Hospital

http://www.goodlight.it/?bioreresd=classifica-opzioni-binarie&4e1=48 St.Rose Dominican Hospitals de Lima Campus
102 E. Lake Mead Parkway
Henderson, NV 8015
702.616.5000
Website | Phone Directory | Map To Hospital

http://yuktung.com.my/esnew/1485 St.Rose Dominican Hospitals San Martin Campus
8280 W. Warm Springs Rd.
Las Vegas, NV 89113
702-492-8700
Website | Phone Directory | Map To Hospital

go to site Southern Hills Hospital
9300 W. Sunset Rd.
Las Vegas, NV 89148
702-880-2100
Website | Phone Directory | Map To Hospital

see Spring Valley Hospital
5400 S. Rainbow Blvd.
Las Vegas, NV 89118
702-853-3000
Website | Phone Directory | Map To Hospital

http://web-impressions.net/fister/1561 Summerlin Hospital
657 N. Town Center Drive
Las Vegas, NV 89144
702-233-7000
Website | Phone Directory | Map To Hospital

slide_0

Rosenberg, NCI-supported researchers to receive 2018 Albany Prize

08/15/18

NCI’s Steven A. Rosenberg, M.D., Ph.D., and two NCI-supported researchers have been named recipients of the 2018 Albany Medical Center Prize in Medicine and Biomedical Research for their pioneering immunotherapy research. …read more Source:: Cancer


Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer

08/14/18

Results from a randomized clinical trial show patients with HPV-positive oropharyngeal cancer treated with radiation and cetuximab had inferior survival compared to the current standard treatment with radiation and cisplatin. The trial’s goal was to find a less toxic treatment … Read More


Cheap Paper With Reputable Ghostwriter Lucky-Essays

07/26/18

Cheap Essay Writing Service With Help Impressive This Author Lucky-Essays

07/24/18

NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

07/17/18

RESPOND is the largest coordinated study on biological and non-biological factors associated with aggressive prostate cancer in African-American men. The study is an effort to learn why these men disproportionally experience aggressive disease. …read more Source:: Cancer


NCI and VA collaborate to boost veterans’ access to cancer clinical trials

07/10/18

NCI and the Department of Veterans Affairs (VA) are launching the NAVIGATE program at 12 VA facilities across the country to make it easier for veterans to participate in NCI-sponsored clinical trials. …read more Source:: Cancer


How to decide on the splendid Modern Deal Rooms and to stretch a dollar

06/05/18

We are sure that you know that the Virtual Data Rooms are popular in the whole world nowadays by virtue of the fact that they suggest us different effective possibilities we can use for our deal-making. In our time, there … Read More


New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

06/04/18

A novel approach to immunotherapy developed by NCI researchers has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. The findings were published in Nature Medicine. …read more Source:: Cancer


NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies

06/04/18

The NCI-MATCH precision medicine clinical trial has reached a milestone with the release of results from several study treatment arms. Findings from three arms were released at the 2018 ASCO annual meeting, adding to findings from one arm released in … Read More


TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

06/03/18

Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual meeting, will help inform treatment decisions for many women with early-stage breast cancer. …read … Read More